U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722832) titled 'Evaluation of the Efficacy of QUITOXIL(R) in Smoking Cessation' on July 20.
Brief Summary: As part of post-marketing clinical monitoring and with a view to applying for the digital medical device Quitoxil(R) to be included on the LPPR list, this prospective, multicentre, controlled, randomised clinical trial aims to evaluate the clinical impact of support provided by Quitoxil(R) as an adjunct to conventional management for patients undergoing smoking cessation who have a tobacco use disorder.
Study Start Date: Oct. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Tobacco Use Disorder
Intervention:
DEVICE: Quitoxil(R)
Quitoxil(R...